Northwestern University

An individual participant data meta-analysis of predictors of adherence to internet-based interventions for depression (2026) Tong L, Panagiotopoulou OM, Miguel C, Harrer M, Amarnath A, Ciharova M, Gemmill AW, et al. Journal article Multinational validation of the PREVENT and SCORE2 cardiovascular risk equations across 6.4 million individuals (2026) Neuen BL, Major RW, Grams ME, Sang Y, Coresh J, Ballew SH, Surapaneni A, et al. Journal article A decade of clinical data with vedolizumab: the past, present, and future (2026) Jairath V, Armuzzi A, Agboton C, Bressler B, Danese S, Dulai PS, Meyer M, et al. Journal article, Review article Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study (2026) Kaulen LD, Nayak L, Karschnia P, Kraai I, Galluzzo D, de Groot FA, Witterholt M, et al. Journal article Apremilast improves skin outcomes in pediatric plaque psoriasis of shorter disease duration: 52-week results from the SPROUT phase 3 trial (2026) Langley RG, Arkin L, Fiorillo L, Eichenfield LF, Lebwohl M, Strober B, Sticherling M, et al. Journal article Noise in the diagnosis of epilepsy by experts (2026) Nascimento FA, McLaren JR, Zhao W, Katyal R, Sheikh IS, Kong WY, Aljaafari D, et al. Journal article PRRX1 -rearranged Fibroblastic Tumors : A Clinicopathologic and Molecular Study of 18 Cases Including a Novel PRRX1::EP300 Fusion (2026) Dehner CA, Torres-Mora J, Thangaiah JJ, Oliveira A, Michal M, Malik F, Din NU, et al. Journal article Cartilage loss is greater in knees with virtual joint replacement status than in matched controls without (2025) Eckstein F, Wirth W, Guermazi A, Roemer F, Nevitt M, Ladel C, Sharma L, et al. Journal article Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis (2025) Ferrante M, Peyrin-Biroulet L, Arkkila P, Armuzzi A, Colombel JF, Danese S, Faggiani R, et al. Journal article YBX1&YBX3 as novel targets to potentiate immune checkpoint blockade response in gliomas. (2025) Ali H, Zhou N, Chen L, van Hijfte L, Tulaiha R, Karri V, Zhou Y, et al. Journal article